Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical ModelsHeather M. Moore, Timothy R. Wilson, Ethan S. Sokol et al.|Molecular Cancer Therapeutics|2019Cited by 10
Evaluation of efficacy and safety of sequential antibody drug conjugates (ADCs) in human epidermal growth factor 2 (HER2)-negative metastatic breast cancerSara Nezirevic, Heather M. Moore, Carey K. Anders et al.|Breast Cancer Research and Treatment|2025Cited by 3